Kerry D. Fisher

2.5k total citations
53 papers, 2.0k citations indexed

About

Kerry D. Fisher is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Kerry D. Fisher has authored 53 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Genetics, 37 papers in Molecular Biology and 29 papers in Oncology. Recurrent topics in Kerry D. Fisher's work include Virus-based gene therapy research (43 papers), CAR-T cell therapy research (29 papers) and RNA Interference and Gene Delivery (24 papers). Kerry D. Fisher is often cited by papers focused on Virus-based gene therapy research (43 papers), CAR-T cell therapy research (29 papers) and RNA Interference and Gene Delivery (24 papers). Kerry D. Fisher collaborates with scholars based in United Kingdom, Czechia and United States. Kerry D. Fisher's co-authors include Leonard W. Seymour, Karel Ulbrich, Vivien Mautner, Yvette Stallwood, Vladimír Šubr, Mark Stevenson, Margaret R. Duffy, Miriam Bazán‐Peregrino, Joshua D. Freedman and Eleanor M. Scott and has published in prestigious journals such as Nucleic Acids Research, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Kerry D. Fisher

53 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kerry D. Fisher United Kingdom 27 1.4k 1.2k 867 273 257 53 2.0k
Giulia Fulci United States 23 1.0k 0.7× 898 0.7× 857 1.0× 191 0.7× 110 0.4× 40 1.9k
DT Curiel United States 26 1.4k 1.0× 1.5k 1.3× 713 0.8× 218 0.8× 182 0.7× 51 2.1k
Frederick J. Kohlhapp United States 14 1.1k 0.8× 919 0.8× 1.3k 1.5× 260 1.0× 238 0.9× 27 2.3k
Kerry Fisher United Kingdom 17 748 0.5× 650 0.5× 606 0.7× 142 0.5× 177 0.7× 28 1.3k
Steve H. Thorne United States 28 2.1k 1.5× 1.3k 1.1× 1.7k 2.0× 569 2.1× 320 1.2× 48 3.2k
Н. В. Белоусова Russia 17 1.8k 1.2× 1.5k 1.2× 1.0k 1.2× 207 0.8× 255 1.0× 72 2.1k
Philippe Erbs France 21 894 0.6× 629 0.5× 586 0.7× 239 0.9× 168 0.7× 52 1.4k
Iulia Diaconu Finland 25 1.3k 0.9× 901 0.7× 1.3k 1.5× 308 1.1× 185 0.7× 37 2.0k
Nancy Smyth Templeton United States 25 767 0.5× 1.7k 1.4× 294 0.3× 140 0.5× 102 0.4× 44 2.2k
Siri Tähtinen Finland 20 837 0.6× 670 0.5× 1.0k 1.2× 226 0.8× 204 0.8× 32 1.6k

Countries citing papers authored by Kerry D. Fisher

Since Specialization
Citations

This map shows the geographic impact of Kerry D. Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerry D. Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerry D. Fisher more than expected).

Fields of papers citing papers by Kerry D. Fisher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerry D. Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerry D. Fisher. The network helps show where Kerry D. Fisher may publish in the future.

Co-authorship network of co-authors of Kerry D. Fisher

This figure shows the co-authorship network connecting the top 25 collaborators of Kerry D. Fisher. A scholar is included among the top collaborators of Kerry D. Fisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerry D. Fisher. Kerry D. Fisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fisher, Kerry D., et al.. (2025). T cell engagers: expanding horizons in oncology and beyond. British Journal of Cancer. 133(9). 1241–1249. 5 indexed citations
2.
Puliyadi, Rathi, Remko Prevo, Gonzalo Rodríguez‐Berriguete, et al.. (2020). External Beam Radiation Therapy and Enadenotucirev: Inhibition of the DDR and Mechanisms of Radiation-Mediated Virus Increase. Cancers. 12(4). 798–798. 15 indexed citations
3.
Lei-Rossmann, Janet, Kerry D. Fisher, Silvio Hemmi, et al.. (2018). Expression of human CD46 and trans-complementation by murine adenovirus 1 fails to allow productive infection by a group B oncolytic adenovirus in murine cancer cells. Journal for ImmunoTherapy of Cancer. 6(1). 55–55. 15 indexed citations
4.
Duffy, Margaret R., Kerry D. Fisher, & Leonard W. Seymour. (2017). Making Oncolytic Virotherapy a Clinical Reality: The European Contribution. Human Gene Therapy. 28(11). 1033–1046. 12 indexed citations
5.
6.
Scott, Eleanor M., Margaret R. Duffy, Joshua D. Freedman, Kerry D. Fisher, & Leonard W. Seymour. (2017). Solid Tumor Immunotherapy with T Cell Engager‐Armed Oncolytic Viruses. Macromolecular Bioscience. 18(1). 60 indexed citations
7.
Di, Ying, Maxine Bauzon, Janet Lei-Rossmann, et al.. (2017). Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus. Molecular Therapy — Oncolytics. 5. 62–74. 40 indexed citations
8.
Di, Ying, Hugo Calderón, Gray Kueberuwa, et al.. (2016). Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators. Molecular Therapy — Oncolytics. 4. 18–30. 43 indexed citations
9.
Hills, Thomas, et al.. (2015). Improved In Vitro Human Tumor Models for Cancer Gene Therapy. Human Gene Therapy. 26(5). 249–256. 7 indexed citations
10.
Di, Ying, Leonard W. Seymour, & Kerry D. Fisher. (2014). Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood. Gene Therapy. 21(4). 440–443. 29 indexed citations
11.
Stevenson, Mark, Robert Carlisle, Benjamin Davies, et al.. (2013). Development of a Positive-readout Mouse Model of siRNA Pharmacodynamics. Molecular Therapy — Nucleic Acids. 2. e133–e133. 8 indexed citations
12.
Green, Nicola K., Ashley Hale, Ryan Cawood, et al.. (2012). Tropism Ablation and Stealthing of Oncolytic Adenovirus Enhances Systemic Delivery to Tumors and Improves Virotherapy of Cancer. Nanomedicine. 7(11). 1683–1695. 23 indexed citations
13.
Sims, Karen, Zubair Ahmed, Martin L. Read, et al.. (2009). In vitro evaluation of a ‘stealth’ adenoviral vector for targeted gene delivery to adult mammalian neurones. The Journal of Gene Medicine. 11(4). 335–344. 7 indexed citations
14.
Green, Nicola K., Jo Morrison, Sarah Hale, et al.. (2008). Retargeting polymer‐coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer. The Journal of Gene Medicine. 10(3). 280–289. 47 indexed citations
15.
Šubr, Vladimír, Libor Kostka, Kerry D. Fisher, et al.. (2008). Coating of adenovirus type 5 with polymers containing quaternary amines prevents binding to blood components. Journal of Controlled Release. 135(2). 152–158. 46 indexed citations
16.
Parker, Alan L., Kerry D. Fisher, David Oupický, et al.. (2005). Enhanced gene transfer activity of peptide-targeted gene-delivery vectors. Journal of drug targeting. 13(1). 39–51. 36 indexed citations
17.
Maruta, Fukuto, Alan L. Parker, Kerry D. Fisher, et al.. (2003). Use of a Phage Display Library to Identify Oligopeptides Binding to the Lumenal Surface of Polarized Endothelium byEx VivoPerfusion of Human Umbilical Veins. Journal of drug targeting. 11(1). 53–59. 22 indexed citations
18.
Maruta, Fukuto, Alan L. Parker, Kerry D. Fisher, et al.. (2002). Identification of FGF receptor-binding peptides for cancer gene therapy. Cancer Gene Therapy. 9(6). 543–552. 53 indexed citations
19.
Stallwood, Yvette, Kerry D. Fisher, P. H. Gallimore, & Vivien Mautner. (2000). Neutralisation of adenovirus infectivity by ascitic fluid from ovarian cancer patients. Gene Therapy. 7(8). 637–643. 55 indexed citations
20.
Fisher, Kerry D., Karel Ulbrich, Vladimír Šubr, et al.. (2000). A versatile system for receptor-mediated gene delivery permits increased entry of DNA into target cells, enhanced delivery to the nucleus and elevated rates of transgene expression. Gene Therapy. 7(15). 1337–1343. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giulia Fulci Breakdown of academic impact, for papers by DT Curiel Breakdown of academic impact, for papers by Frederick J. Kohlhapp Breakdown of academic impact, for papers by Kerry Fisher Breakdown of academic impact, for papers by Steve H. Thorne Breakdown of academic impact, for papers by Н. В. Белоусова Breakdown of academic impact, for papers by Philippe Erbs Breakdown of academic impact, for papers by Iulia Diaconu Breakdown of academic impact, for papers by Nancy Smyth Templeton Breakdown of academic impact, for papers by Siri Tähtinen
Rankless by CCL
2026